thiorphan has been researched along with atrial natriuretic factor in 64 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 8 (12.50) | 18.7374 |
1990's | 45 (70.31) | 18.2507 |
2000's | 10 (15.63) | 29.6817 |
2010's | 1 (1.56) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Corvol, P; el Amrani, AI; Fournié-Zaluski, MC; Michel, JB; Pham, I; Roques, B | 1 |
Beaumont, A; Ficheux, D; Fournié-Zaluski, MC; Lucas, E; Michel, JB; Roques, BP; Soleilhac, JM; Turcaud, S | 1 |
Casley, DJ; Haslanger, MF; Johnston, CI; Kanazawa, M; Sybertz, EJ | 1 |
Hayakawa, H; Hirata, Y; Kangawa, K; Kojima, M; Matsuo, H; Matsuoka, H; Sugimoto, T; Suzuki, E | 1 |
Bralet, J; Gros, C; Mossiat, C; Schwartz, JC | 1 |
Duboc, D; Fouchard, J; Guérin, F; Muffat-Joly, M; Schwartz, JC; Varin, J; Weber, S | 1 |
Chiyotani, A; Horii, S; Isono, K; Kanemura, T; Kobayashi, K; Sakai, N; Takeuchi, S; Takizawa, T; Tamaoki, J; Yamawaki, I | 1 |
Hayakawa, H; Hirata, Y; Kangawa, K; Matsuo, H; Matsuoka, H; Sugimoto, T; Suzuki, E | 1 |
Chiu, PJ; Sybertz, EJ; Vemulapalli, S; Watkins, RW | 1 |
Advenier, C; Candenas, ML; Devillier, P; Naline, E; Puybasset, L | 1 |
Ardaillou, R; Bodin, F; Dussaule, JC; Grangé, JD; Gros, C; Lecomte, JM; Schwartz, JC; Wolf, JP | 1 |
Hirata, Y | 1 |
Bralet, J; Danvy, D; Duhamel, L; Duhamel, P; Gros, C; Lecomte, JM; Noël, N; Plaquevent, JC; Schwartz, JC; Souque, A | 1 |
Castaigne, A; Duboc, D; Dubois-Rande, JL; Gros, C; Kahn, JC; Lecomte, JM; Lim-Alexandre, C; Merlet, P; Patey, M; Schwartz, JC | 1 |
Barclay, PL; Danilewicz, JC; Samuels, GM | 1 |
McGraw, DE; Smits, GJ; Trapani, AJ | 1 |
Gros, C; Schwartz, JC; Souque, A | 2 |
Bralet, J; Charpentier, S; Gros, C; Lecomte, JM; Mossiat, C; Schwartz, JC | 1 |
Blaine, EB; McGraw, DE; Smits, GJ; Trapani, AJ | 1 |
Blaine, EH; Blehm, DJ; Koepke, JP; Schuh, JR; Tyler, LD | 1 |
Ardaillou, R; Baumer, P; Chaignon, B; Cournot, A; Duchier, J; Dussaule, JC; Gros, C; Lecomte, JM; Lim, C; Souque, A | 1 |
Needleman, P; Settle, SL; Stockmann, PT; Wilkins, MR | 1 |
Blaine, EH; Bovy, PR; Hartupee, DA; Koepke, JP; Mehta, PP; Olins, GM; Spear, KL; Trapani, AJ; Tyler, LD | 1 |
McMartin, C; McNeal, RB; Webb, RL; Yasay, GD; Zimmerman, MB | 1 |
Blaine, EH; Koepke, JP; McGraw, DE; Olins, GM; Smits, GJ; Spear, KL; Trapani, AJ | 1 |
Bovy, PR; Krieter, PA; Olins, GM; Spear, KL; Trapani, AJ | 1 |
Durley, RC; Krieter, PA; Olins, GM; Verrett, SP | 1 |
Baumer, P; Cournot, A; Duchier, J; Gros, C; Lecomte, JM; Schwartz, JC; Souque, A | 1 |
Charles, D; Erion, MD; Gilligan, JP; Koehn, JA; McMartin, C; Miller, MJ; Palmesino, RA; Sharif, R; Tamburini, PP | 1 |
Anderson, S; Brenner, BM; Gunning, M; Lafferty, HM; Silva, P; Zimmerman, MB | 1 |
Blaine, EH; Bovy, PR; Koepke, JP; Olins, GM; Spear, KL; Trapani, AJ; Tyler, LD | 1 |
Beil, ME; Coté, DT; de Lombaert, S; Erion, MD; Gerlock, TE; Ghai, RD; Hopkins, MF; Peppard, JV; Trapani, AJ; Webb, RL | 1 |
Dressel, J; Hirth-Dietrich, C; Kazda, S; Stasch, JP; Voges, KP; Wegner, M | 1 |
Hirth-Dietrich, C; Knorr, A; Stasch, JP; Wegner, M | 1 |
Brouard, R; Brunner, HR; Burnier, M; Favrat, B; Lecomte, JM; Nussberger, J; Waeber, B | 1 |
Berry, C; De Lombaert, S; Ghai, RD; Ksander, GM; Sakane, Y; Trapani, AJ | 1 |
Angus, RM; Chalmers, GW; Millar, EA; Thomson, NC | 2 |
De Prez, E; Deschodt-Lanckman, M; Nortier, J; Pauwels, S | 1 |
Cernacek, P; Mulay, S; Omer, S; Varma, DR | 1 |
Goto, A; Hayakawa, H; Hirata, Y; Kangawa, K; Kimura, K; Matsuo, H; Minamino, N; Omata, M; Suzuki, E; Suzuki, Y | 1 |
Ardaillou, R; Dussaule, JC; Gros, C; Lecomte, JM; Michel, C; Mignon, F; Peraldi, MN | 1 |
Berry, CJ; Fink, CA; Ghai, RD; Qiao, Y; Sakane, Y; Trapani, AJ | 1 |
Beslot, F; Claperon, N; Fournie-Zaluski, MC; Peyroux, J; Roques, BP | 1 |
Hirth-Dietrich, C; Stasch, JP; Wegner, M | 1 |
Tucker, VL | 1 |
Ganten, D; Stasch, JP; Wegner, M | 1 |
Bohacek, R; de Jesus, R; Ghai, RD; Ksander, GM; McMartin, C; Trapani, A; Yuan, A | 1 |
Morazzoni, G; Norcini, G; Pocchiari, F; Santangelo, F; Semeraro, C | 1 |
Hayashi, I; Ito, H; Katori, M; Majima, M; Nakajima, S; Yajima, Y | 1 |
Ferro, CJ; Haynes, WG; Spratt, JC; Webb, DJ | 1 |
Hashimoto, Y; Inui, K; Itoh, H; Nakao, K; Ozaki, J; Shimizu, H | 1 |
Bryant, HJ; Chen, S; Ghai, RD; Haddy, FJ; Pamnani, MB; Schooley, JF | 1 |
Goetze, L; Sisson, D; Solter, P; Thomas, W | 1 |
Capasso, G; Ciani, F; De Santo, NG; Pica, A; Rizzo, A; Russo, F; Unwin, R | 1 |
Brandenberger, G; Charloux, A; Doutreleau, S; Geny, B; Hannedouche, T; Piquard, F; Richard, R | 1 |
Houard, X; Jacob, MP; Meilhac, O; Michel, JB; Mtairag, el M; Oudghiri, M; Pasquier, C; Rais, S | 1 |
Gerbes, AL; Lee, SS; Li, Y; Liu, H; Park, KS; Swain, MG; Zhang, Y | 1 |
Cruden, NL; Fox, KA; Johnston, NR; Ludlam, CA; Newby, DE | 1 |
Berlan, M; Galitzky, J; Klimcakova, E; Lafontan, M; Moro, C | 1 |
Honda, J; Kimura, NY; Maeshiro, K; Matsuo, T; Mifune, H; Shirouzu, K; Takamori, S | 1 |
Baliga, RS; Hobbs, AJ; Lopez-Torondel, B; MacAllister, RJ; Madhani, M; Selwood, D; Visintin, C; Wilkins, MR; Zhao, L | 1 |
Batenburg, WW; Bhaggoe, UM; Clahsen-van Groningen, MC; de Vries, R; Domenig, O; Friesema, EC; Garrelds, IM; Hoorn, EJ; Jan Danser, AH; Leijten, FP; Poglitsch, M; Roksnoer, LC; van Veghel, R | 1 |
1 review(s) available for thiorphan and atrial natriuretic factor
Article | Year |
---|---|
[Effect of sinorphan, an endopeptidase inhibitor on severe congestive cardiac insufficiency].
Topics: Adult; Aged; Atrial Natriuretic Factor; Blood Pressure; Creatinine; Cyclic GMP; Diuresis; Female; Heart Failure; Humans; Male; Middle Aged; Natriuresis; Neprilysin; Thiorphan | 1991 |
12 trial(s) available for thiorphan and atrial natriuretic factor
Article | Year |
---|---|
[Effect of sinorphan, an endopeptidase inhibitor on severe congestive cardiac insufficiency].
Topics: Adult; Aged; Atrial Natriuretic Factor; Blood Pressure; Creatinine; Cyclic GMP; Diuresis; Female; Heart Failure; Humans; Male; Middle Aged; Natriuresis; Neprilysin; Thiorphan | 1991 |
Effect of sinorphan, an enkephalinase inhibitor, on plasma atrial natriuretic factor and sodium urinary excretion in cirrhotic patients with ascites.
Topics: Administration, Oral; Adult; Aldosterone; Atrial Natriuretic Factor; Cyclic GMP; Dose-Response Relationship, Drug; Double-Blind Method; Female; Heart Rate; Humans; Liver Cirrhosis; Male; Middle Aged; Neprilysin; Renin; Sodium; Thiorphan | 1991 |
Effect of sinorphan on plasma atrial natriuretic factor in congestive heart failure.
Topics: Administration, Oral; Atrial Natriuretic Factor; Clinical Trials as Topic; Drug Administration Schedule; Heart Failure; Humans; Male; Neprilysin; Stimulation, Chemical; Thiorphan | 1990 |
Stereoselective protection of exogenous and endogenous atrial natriuretic factor by enkephalinase inhibitors in mice and humans.
Topics: Administration, Oral; Adult; Animals; Atrial Natriuretic Factor; Binding, Competitive; Chemical Phenomena; Chemistry; Cyclic GMP; Double-Blind Method; Humans; Injections, Intravenous; Kidney; Male; Mice; Neprilysin; Random Allocation; Thiorphan; Time Factors | 1990 |
Protection of atrial natriuretic factor against degradation: diuretic and natriuretic responses after in vivo inhibition of enkephalinase (EC 3.4.24.11) by acetorphan.
Topics: Animals; Atrial Natriuretic Factor; Diuresis; Humans; Hydrolysis; Kidney; Kinetics; Male; Mice; Natriuresis; Neprilysin; Thiorphan | 1989 |
Neutral endopeptidase versus angiotensin converting enzyme inhibition in essential hypertension.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Blood Pressure; Captopril; Cross-Over Studies; Double-Blind Method; Female; Humans; Hypertension; Male; Middle Aged; Neprilysin; Protease Inhibitors; Thiorphan | 1995 |
Effect of inhaled atrial natriuretic peptide and a neutral endopeptidase inhibitor on histamine-induced bronchoconstriction.
Topics: Administration, Inhalation; Adult; Asthma; Atrial Natriuretic Factor; Bronchial Provocation Tests; Bronchoconstriction; Double-Blind Method; Female; Forced Expiratory Volume; Histamine; Humans; Male; Neprilysin; Thiorphan | 1995 |
Inhibition of neutral endopeptidase stimulates renal sodium excretion in patients with chronic renal failure.
Topics: Adult; Aged; Aged, 80 and over; Atrial Natriuretic Factor; Cyclic GMP; Double-Blind Method; Female; Humans; Kidney; Kidney Failure, Chronic; Male; Middle Aged; Neprilysin; Sodium; Sodium, Dietary; Thiorphan; Time Factors | 1993 |
Effect of inhaled thiorphan, a neutral endopeptidase inhibitor, on the bronchodilator response to inhaled atrial natriuretic peptide (ANP).
Topics: Administration, Inhalation; Adult; Albuterol; Asthma; Atrial Natriuretic Factor; Bronchodilator Agents; Cross-Over Studies; Double-Blind Method; Drug Synergism; Female; Forced Expiratory Volume; Humans; Lung; Male; Middle Aged; Protease Inhibitors; Thiorphan | 1996 |
Inhibition of neutral endopeptidase causes vasoconstriction of human resistance vessels in vivo.
Topics: Adult; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Blood Pressure; Coronary Vessels; Cross-Over Studies; Cyclohexanecarboxylic Acids; Enalapril; Endothelin-1; Humans; Hypertension; Injections, Intra-Arterial; Male; Middle Aged; Myocardium; Neprilysin; Peptides, Cyclic; Protease Inhibitors; Renin; Single-Blind Method; Thiorphan; Vasoconstriction | 1998 |
Hormonal, renal, hemodynamic responses to acute neutral endopeptidase inhibition in heart transplant patients.
Topics: Adult; Atrial Natriuretic Factor; Blood Pressure; Cyclic GMP; Cyclosporine; Double-Blind Method; Endothelin-1; Glomerular Filtration Rate; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Natriuresis; Neprilysin; Protease Inhibitors; Renal Circulation; Thiorphan; Vascular Resistance | 2002 |
Neutral endopeptidase inhibition augments vascular actions of bradykinin in patients treated with angiotensin-converting enzyme inhibition.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Bradykinin; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Interactions; Drug Therapy, Combination; Female; Heart Failure; Humans; Male; Middle Aged; Neprilysin; Nitroprusside; Protease Inhibitors; Receptor, Bradykinin B1; Thiorphan; Tissue Plasminogen Activator; Vasodilation; Vasodilator Agents | 2004 |
52 other study(ies) available for thiorphan and atrial natriuretic factor
Article | Year |
---|---|
Effects of the selective neutral endopeptidase inhibitor, retrothiorphan, on renal function and blood pressure in conscious normotensive Wistar and hypertensive DOCA-salt rats.
Topics: Animals; Atrial Natriuretic Factor; Blood Pressure; Bradykinin; Cyclic GMP; Desoxycorticosterone; Diuresis; Hypertension; Kidney; Kininogens; Male; Natriuresis; Neprilysin; Rats; Rats, Wistar; Sulfhydryl Compounds; Thiorphan | 1992 |
A 94-kDa protein, identified as neutral endopeptidase-24.11, can inactivate atrial natriuretic peptide in the vascular endothelium.
Topics: Amino Acid Sequence; Animals; Atrial Natriuretic Factor; Autoradiography; Chromatography, High Pressure Liquid; Electrophoresis, Polyacrylamide Gel; Endothelium, Vascular; Enkephalin, Leucine-2-Alanine; Humans; In Vitro Techniques; Molecular Sequence Data; Neprilysin; Rats; Sulfhydryl Compounds; Thiorphan | 1992 |
Localization and characterization of neutral metalloendopeptidase (EC 3.4.24.11), the degradative enzyme for atrial natriuretic peptide, in rat kidney using a radioiodinated neutral metalloendopeptidase inhibitor.
Topics: Animals; Atrial Natriuretic Factor; Autoradiography; Binding, Competitive; Cell Membrane; Dipeptides; Drug Interactions; Glycopeptides; Iodine Radioisotopes; Kidney; Male; Neprilysin; Phenols; Phenylalanine; Rats; Rats, Inbred Strains; Thiorphan | 1992 |
Role of endogenous ANP in sodium excretion in rats with experimental pulmonary hypertension.
Topics: Animals; Atrial Natriuretic Factor; Hypertension, Pulmonary; Immune Sera; Male; Monocrotaline; Natriuresis; Rats; Rats, Inbred Strains; Thiorphan | 1992 |
Thiorphan-induced natriuresis in volume-expanded rats: roles of endogenous atrial natriuretic factor and kinins.
Topics: Animals; Antibodies; Atrial Function; Atrial Natriuretic Factor; Bradykinin; Cardiac Volume; Cyclic GMP; Kidney; Kinins; Male; Natriuresis; Neprilysin; Rats; Rats, Inbred Strains; Thiorphan | 1991 |
Atrial natriuretic factor inhibits ciliary motility in cultured rabbit tracheal epithelium.
Topics: Animals; Atrial Natriuretic Factor; Captopril; Cells, Cultured; Cilia; Enzyme Inhibitors; Epithelium; Glycopeptides; Indomethacin; Kinetics; Leucine; Leupeptins; Male; Masoprocol; Methylene Blue; Movement; Piroxicam; Purinones; Rabbits; Thiorphan; Trachea | 1991 |
Role of endogenous atrial natriuretic peptide in regulating sodium excretion in spontaneously hypertensive rats. Effects of neutral endopeptidase inhibition.
Topics: Animals; Atrial Natriuretic Factor; Bradykinin; Immune Sera; Male; Natriuresis; Neprilysin; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Thiorphan | 1991 |
Neutral metalloendopeptidase inhibitors as ANF potentiators: sites and mechanisms of action.
Topics: Animals; Antihypertensive Agents; Atrial Natriuretic Factor; Blood Pressure; Bradykinin; Desoxycorticosterone; Dioxolanes; Dipeptides; Drug Synergism; Hypertension; Iodine Radioisotopes; Kinins; Male; Metalloendopeptidases; Rats; Rats, Inbred Strains; Thiorphan | 1991 |
Effect of atrial natriuretic peptide and on atriopeptins on the human isolated bronchus. Comparison with the reactivity of the guinea-pig isolated trachea.
Topics: Amino Acid Sequence; Animals; Atrial Natriuretic Factor; Bronchi; Drug Synergism; Epithelium; Guinea Pigs; Humans; In Vitro Techniques; Kinetics; Male; Molecular Sequence Data; Muscle Contraction; Muscle Relaxation; Peptide Fragments; Thiorphan; Trachea | 1991 |
[Clinical significance and therapeutic application of atrial natriuretic peptides].
Topics: Animals; Atrial Natriuretic Factor; Glycopeptides; Heart Atria; Heart Failure; Hemodynamics; Humans; Receptors, Atrial Natriuretic Factor; Receptors, Cell Surface; Thiorphan | 1991 |
Mixed inhibitors of angiotensin-converting enzyme (EC 3.4.15.1) and enkephalinase (EC 3.4.24.11): rational design, properties, and potential cardiovascular applications of glycopril and alatriopril.
Topics: Alanine; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Natriuretic Factor; Blood Pressure; Cell Membrane; Cyclic GMP; Dioxoles; Dipeptides; Diuresis; Glycine; Humans; Lung; Male; Mice; Molecular Structure; Natriuresis; Neprilysin; Peptidyl-Dipeptidase A; Rats; Rats, Inbred Strains; Thiorphan | 1991 |
Inhibitory potencies of UK-69 578 and thiorphan.
Topics: Atrial Natriuretic Factor; Carbamates; Cyclohexanecarboxylic Acids; Depression, Chemical; Propionates; Substrate Specificity; Thiorphan | 1990 |
Interaction of ANP and bradykinin during endopeptidase 24.11 inhibition: renal effects.
Topics: Animals; Atrial Natriuretic Factor; Bradykinin; Captopril; Diuretics; Drug Synergism; Kidney; Male; Natriuresis; Neprilysin; Peptide Fragments; Rats; Rats, Inbred Strains; Thiorphan | 1990 |
Inactivation of atrial natriuretic factor in mice in vivo: crucial role of enkephalinase (EC 3.4.24.11).
Topics: Administration, Oral; Animals; Atrial Natriuretic Factor; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Injections, Intraperitoneal; Iodine Radioisotopes; Kidney; Male; Mice; Neprilysin; Protease Inhibitors; Thiorphan; Time Factors | 1990 |
Diuretic and natriuretic responses in rats treated with enkephalinase inhibitors.
Topics: Animals; Atrial Natriuretic Factor; Chromatography, High Pressure Liquid; Diuresis; Injections, Intravenous; Male; Natriuresis; Neprilysin; Potassium; Prodrugs; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Thiorphan; Time Factors | 1990 |
Effect of endopeptidase 24.11 inhibition in conscious cardiomyopathic hamsters.
Topics: Animals; Atrial Natriuretic Factor; Cardiomyopathies; Cricetinae; Heart Failure; Male; Neprilysin; Sodium; Thiorphan | 1990 |
Chronic atriopeptin regulation of arterial pressure in conscious hypertensive rats.
Topics: Animals; Atrial Natriuretic Factor; Blood Pressure; Male; Peptide Fragments; Rats; Rats, Inbred SHR; Thiorphan; Time Factors | 1990 |
Degradation of atrial natriuretic factor in mouse blood in vitro and in vivo: role of enkephalinase (EC 3.4.24.11).
Topics: Animals; Atrial Natriuretic Factor; Chromatography, High Pressure Liquid; Half-Life; Hydrolysis; In Vitro Techniques; Iodine Radioisotopes; Male; Metabolic Clearance Rate; Mice; Neprilysin; Thiorphan | 1990 |
Maximizing the natriuretic effect of endogenous atriopeptin in a rat model of heart failure.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Antibodies, Monoclonal; Atrial Natriuretic Factor; Blood Pressure; Cyclic GMP; Disease Models, Animal; Heart Failure; Male; Purinones; Rats; Rats, Inbred Strains; Reference Values; Sodium; Thiorphan | 1990 |
Atriopeptin regulation and renal function in conscious spontaneously hypertensive rats.
Topics: Animals; Atrial Natriuretic Factor; Blood Pressure; Drug Interactions; Guanosine Monophosphate; Male; Natriuresis; Peptide Fragments; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Thiorphan; Time Factors | 1990 |
Degradation of atrial natriuretic peptide: pharmacologic effects of protease EC 24.11 inhibition.
Topics: Animals; Atrial Natriuretic Factor; Blood Pressure; Cyclic GMP; Glycopeptides; Heart Rate; In Vitro Techniques; Kidney; Male; Protease Inhibitors; Rats; Rats, Inbred SHR; Sodium; Thiorphan; Time Factors | 1989 |
Thiorphan, an inhibitor of endopeptidase 24.11, potentiates the natriuretic activity of atrial natriuretic peptide.
Topics: Animals; Atrial Natriuretic Factor; Blood Pressure; Captopril; Drug Synergism; Hemodynamics; Iodine Radioisotopes; Kidney; Male; Natriuresis; Neprilysin; Peptide Fragments; Rats; Rats, Inbred Strains; Sodium; Thiorphan | 1989 |
Specific inhibitors of endopeptidase 24.11 inhibit the metabolism of atrial natriuretic peptides in vitro and in vivo.
Topics: Animals; Atrial Natriuretic Factor; Dipeptides; Kidney; Male; Microvilli; Neprilysin; Protease Inhibitors; Rabbits; Rats; Thiorphan | 1989 |
In vivo metabolism of atrial natriuretic peptide: identification of plasma metabolites and enzymes responsible for their generation.
Topics: Animals; Atrial Natriuretic Factor; Carboxypeptidases; Endopeptidases; Kidney; Phenylalanine; Rats; Thiorphan; Tyrosine | 1989 |
Rat vascular tissue contains a neutral endopeptidase capable of degrading atrial natriuretic peptide.
Topics: Animals; Atrial Natriuretic Factor; Blood Vessels; Endopeptidases; Female; Hydrogen-Ion Concentration; Hydrolysis; Male; Rabbits; Rats; Rats, Inbred Strains; Thiorphan | 1989 |
Enkephalinase inhibition increases plasma atrial natriuretic peptide levels, glomerular filtration rate, and urinary sodium excretion in rats with reduced renal mass.
Topics: Animals; Anti-Bacterial Agents; Atrial Natriuretic Factor; Blood Pressure; Cyclic GMP; Glomerular Filtration Rate; Glycopeptides; Kidney; Male; Nephrectomy; Neprilysin; Rats; Rats, Inbred Strains; Reference Values; Sodium; Thiorphan | 1989 |
Interaction of non-guanylate cyclase-linked atriopeptin receptor ligand and endopeptidase inhibitor in conscious rats.
Topics: Animals; Atrial Natriuretic Factor; Blood Pressure; Diuresis; Guanylate Cyclase; Male; Natriuresis; Peptide Fragments; Protease Inhibitors; Rabbits; Rats; Rats, Inbred Strains; Receptors, Atrial Natriuretic Factor; Receptors, Cell Surface; Structure-Activity Relationship; Thiorphan | 1989 |
Pharmacologic profile of CGS 24128, a potent, long-acting inhibitor of neutral endopeptidase 24.11.
Topics: Amino Acid Sequence; Animals; Atrial Natriuretic Factor; beta-Alanine; Blood Pressure; Desoxycorticosterone; Diuresis; Heart Rate; Hypertension; Kidney; Male; Molecular Sequence Data; Natriuresis; Neprilysin; Organophosphonates; Peptide Fragments; Rats; Rats, Sprague-Dawley; Thiorphan | 1994 |
Interaction of a neutral endopeptidase inhibitor with an ANP-C receptor ligand in anesthetized dogs.
Topics: Animals; Atrial Natriuretic Factor; Cardiovascular Diseases; Cyclic GMP; Diuresis; Dogs; Drug Interactions; Female; Kidney; Ligands; Natriuresis; Neprilysin; Oligopeptides; Protease Inhibitors; Receptors, Atrial Natriuretic Factor; Renin; Thiorphan | 1995 |
Prolonged inhibition of neutral endopeptidase 24.11 by sinorphan in stroke-prone spontaneously hypertensive rats.
Topics: Animals; Atrial Natriuretic Factor; Blood Pressure; Body Weight; Heart Failure; Hemodynamics; Kidney Function Tests; Neprilysin; Rats; Rats, Inbred SHR; Sodium, Dietary; Thiorphan; Time Factors | 1995 |
A rapid indirect method to determine the plasma concentrations of neutral endopeptidase inhibitors.
Topics: Animals; Atrial Natriuretic Factor; beta-Alanine; Cyclohexanecarboxylic Acids; Enzyme Inhibitors; Kidney Cortex; Male; Methods; Neprilysin; Organophosphonates; Rats; Rats, Sprague-Dawley; Thiorphan | 1995 |
Human neutrophil and plasma endopeptidase 24.11: quantification and respective roles in atrial natriuretic peptide hydrolysis.
Topics: Amino Acid Sequence; Atrial Natriuretic Factor; Humans; Hydrolysis; Molecular Sequence Data; Neprilysin; Neutrophils; Oligopeptides; Peptide Fragments; Reference Values; Substrate Specificity; Thiorphan | 1995 |
Attenuation of renal effects of atrial natriuretic factor during rat pregnancy.
Topics: Animals; Atrial Natriuretic Factor; Blood Pressure; Cyclic GMP; Diuresis; Female; Glomerular Filtration Rate; Kidney; Natriuresis; Peptide Fragments; Pregnancy; Pregnancy, Animal; Rats; Rats, Sprague-Dawley; Thiorphan | 1995 |
Mechanisms underlying the augmented responses of deoxycorticosterone acetate-salt hypertensive rats to neutral endopeptidase inhibitors.
Topics: Animals; Antihypertensive Agents; Atrial Natriuretic Factor; Base Sequence; Blood Pressure; Desoxycorticosterone; Hypertension; Indans; Male; Molecular Sequence Data; Neprilysin; Polysaccharides; Propionates; Rats; Rats, Wistar; Sodium Chloride; Thiorphan | 1994 |
New alpha-thiol dipeptide dual inhibitors of angiotensin-I converting enzyme and neutral endopeptidase EC 3.4.24.11.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Natriuretic Factor; Blood Pressure; Captopril; Dipeptides; Magnetic Resonance Spectroscopy; Male; Neprilysin; Peptidyl-Dipeptidase A; Protease Inhibitors; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Sulfhydryl Compounds; Thiorphan; Tryptophan | 1995 |
Effect of endopeptidase-24.11 inhibitors and C-ANP receptor ligand on responses evoked in arterioles of rat cremaster muscle by atrial natriuretic peptide.
Topics: Abdominal Muscles; Adenosine; Administration, Topical; Animals; Arterioles; Atrial Natriuretic Factor; Blood Pressure; Dipeptides; Injections, Intravenous; Male; Neprilysin; Nitroprusside; Peptide Fragments; Protease Inhibitors; Rats; Rats, Sprague-Dawley; Thiorphan; Vasodilator Agents | 1995 |
Role of neutral endopeptidase 24.11 in AV fistular rat model of heart failure.
Topics: Angiotensin I; Animals; Aorta; Arteriovenous Fistula; Atrial Natriuretic Factor; Disease Models, Animal; Heart Failure; Natriuretic Peptide, Brain; Neprilysin; Nerve Tissue Proteins; Protease Inhibitors; Rats; Rats, Sprague-Dawley; Renin; Sodium; Thiorphan; Venae Cavae | 1996 |
Contribution of ANP to plasma protein escape during VE: effects of thiorphan and atrial appendectomy.
Topics: Animals; Appendectomy; Atrial Natriuretic Factor; Biological Transport; Blood Pressure; Blood Proteins; Body Fluids; Male; Plasma Substitutes; Rats; Rats, Wistar; Serum Albumin, Bovine; Thiorphan; Tissue Distribution | 1996 |
Neutral endopeptidase inhibition potentiates the effects of natriuretic peptides in renin transgenic rats.
Topics: Animals; Animals, Genetically Modified; Atrial Natriuretic Factor; Blood Pressure; Cyclic GMP; Disease Models, Animal; Drug Therapy, Combination; Electrolytes; Hypertension; Mice; Natriuretic Peptide, Brain; Natriuretic Peptide, C-Type; Neprilysin; Protease Inhibitors; Proteins; Rats; Rats, Sprague-Dawley; Renin; Sodium; Thiorphan | 1996 |
Ortho-substituted benzofused macrocyclic lactams as zinc metalloprotease inhibitors.
Topics: Animals; Atrial Natriuretic Factor; Binding Sites; Drug Synergism; Lactams; Models, Chemical; Models, Molecular; Neprilysin; Rats; Software; Thiorphan | 1997 |
Novel selective thiol inhibitors of neutral endopeptidase containing heterocycles at P'2 position.
Topics: Atrial Natriuretic Factor; Models, Chemical; Neprilysin; Peptidyl-Dipeptidase A; Protease Inhibitors; Structure-Activity Relationship; Thiorphan | 1997 |
Effects of a neutral endopeptidase inhibitor, BP102, on the development of deoxycorticosterone acetate-salt hypertension in kininogen-deficient Brown Norway Katholiek rats.
Topics: Administration, Oral; Animals; Atrial Natriuretic Factor; Desoxycorticosterone; Drug Administration Schedule; Enzyme Inhibitors; Heart; Hypertension; Kidney; Kininogens; Kinins; Male; Neprilysin; Organ Size; Prodrugs; Rats; Rats, Inbred BN; Rats, Sprague-Dawley; Sodium Chloride; Thiorphan; Time Factors | 1998 |
Enzymatic inactivation of major circulating forms of atrial and brain natriuretic peptides.
Topics: Animals; Atrial Natriuretic Factor; Cell Culture Techniques; Cyclic GMP; Glycopeptides; Humans; LLC-PK1 Cells; Male; Natriuresis; Neprilysin; Nitrobenzenes; Protease Inhibitors; Rats; Rats, Wistar; Swine; Thiorphan | 1999 |
Effects of a neutral endoprotease enzyme inhibitor, thiorphan, on hemodynamics and renal excretory function in four models of experimental hypertension.
Topics: Animals; Atrial Natriuretic Factor; Biomarkers; Blood Pressure; Cyclic GMP; Hypertension; Infusions, Intravenous; Kidney; Male; Potassium; Protease Inhibitors; Rats; Rats, Inbred SHR; Sodium; Thiorphan; Urodynamics | 2000 |
Intrarenal effects of ecadotril during acute volume expansion in dogs with congestive heart failure.
Topics: Animals; Atrial Natriuretic Factor; Dogs; Glomerular Filtration Rate; Heart Failure; Kidney; Male; Neprilysin; Protease Inhibitors; Renal Circulation; Thiorphan | 2000 |
Inhibition of neutral endopeptidase potentiates the effects of atrial natriuretic peptide on acute cyclosporin-induced nephrotoxicity.
Topics: Acute Disease; Animals; Atrial Natriuretic Factor; Cyclosporine; Drug Synergism; Glomerular Filtration Rate; Immunosuppressive Agents; Injections, Intravenous; Inulin; Kidney; Male; Neprilysin; Protease Inhibitors; Rats; Rats, Wistar; Sodium Chloride; Thiorphan; Tritium | 2000 |
Pharmacological potentiation of natriuretic peptide limits polymorphonuclear neutrophil-vascular cell interactions.
Topics: Atrial Natriuretic Factor; Cell Adhesion; Cell Communication; Cell Degranulation; Culture Media, Conditioned; Drug Synergism; Endothelium, Vascular; Enzyme Inhibitors; Fibronectins; Humans; Hypoxia; Leukocyte Elastase; Matrix Metalloproteinase 9; Muscle, Smooth, Vascular; Neprilysin; Neutrophil Activation; Neutrophils; Respiratory Burst; Thiorphan; Umbilical Veins | 2002 |
Effects of the neutral endopeptidase inhibitor thiorphan on cardiovascular and renal function in cirrhotic rats.
Topics: Animals; Atrial Natriuretic Factor; Cardiovascular Physiological Phenomena; Cyclic GMP; Endothelin-1; Glomerular Filtration Rate; Hemodynamics; Kidney; Liver Cirrhosis, Experimental; Natriuresis; Neprilysin; Rats; Rats, Sprague-Dawley; Renal Circulation; Sodium; Sodium-Potassium-Exchanging ATPase; Thiorphan | 2003 |
Phosphodiesterase-5A and neutral endopeptidase activities in human adipocytes do not control atrial natriuretic peptide-mediated lipolysis.
Topics: 1-Methyl-3-isobutylxanthine; Adipocytes; Adult; Atrial Natriuretic Factor; Blotting, Western; Cells, Cultured; Cyclic AMP; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 5; Dose-Response Relationship, Drug; Female; Gene Expression Profiling; Humans; Kinetics; Lipolysis; Neprilysin; Phosphodiesterase 5 Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Thiorphan; Time Factors | 2007 |
Changes in A-type natriuretic peptide and its receptors induced by a neutral endopeptidase inhibitor in a rat model of sepsis.
Topics: Animals; Atrial Natriuretic Factor; Disease Models, Animal; Lung; Male; Protease Inhibitors; Rats; Receptors, Atrial Natriuretic Factor; Sepsis; Thiorphan | 2008 |
Synergy between natriuretic peptides and phosphodiesterase 5 inhibitors ameliorates pulmonary arterial hypertension.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Atrial Natriuretic Factor; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Hypertension, Pulmonary; Male; Neprilysin; Piperazines; Protease Inhibitors; Pulmonary Artery; Purines; Rats; Rats, Sprague-Dawley; Sildenafil Citrate; Sulfones; Thiorphan; Treatment Outcome; Vascular Resistance; Vasodilation; Vasodilator Agents | 2008 |
Optimum AT1 receptor-neprilysin inhibition has superior cardioprotective effects compared with AT1 receptor blockade alone in hypertensive rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Arterial Pressure; Atrial Natriuretic Factor; Biphenyl Compounds; Body Weight; Endothelin B Receptor Antagonists; Endothelin-1; Irbesartan; Kidney; Myocardium; Myocytes, Cardiac; Neprilysin; Oligopeptides; Organ Size; Piperidines; Protease Inhibitors; Rats; Receptor, Angiotensin, Type 1; Receptor, Endothelin B; Renin-Angiotensin System; Sodium-Hydrogen Exchanger 3; Sodium-Hydrogen Exchangers; Tetrazoles; Thiorphan; Up-Regulation; Vasoconstriction; Vasodilation | 2015 |